AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 182 filers reported holding AXSOME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $108,000 | -27.5% | 1,504 | -17.0% | 0.01% | -30.0% |
| Q2 2020 | $149,000 | +62.0% | 1,811 | +16.2% | 0.01% | +42.9% |
| Q1 2020 | $92,000 | -37.4% | 1,558 | +9.4% | 0.01% | -22.2% |
| Q4 2019 | $147,000 | +764.7% | 1,424 | +80.9% | 0.01% | +800.0% |
| Q3 2019 | $17,000 | +750.0% | 787 | +439.0% | 0.00% | – |
| Q1 2019 | $2,000 | -71.4% | 146 | -94.2% | 0.00% | -100.0% |
| Q4 2018 | $7,000 | -50.0% | 2,533 | -37.2% | 0.00% | 0.0% |
| Q3 2018 | $14,000 | -99.6% | 4,034 | +225.8% | 0.00% | – |
| Q2 2018 | $3,962,000 | +131966.7% | 1,238 | +3.6% | 0.00% | – |
| Q1 2018 | $3,000 | -62.5% | 1,195 | -11.7% | 0.00% | -100.0% |
| Q4 2017 | $8,000 | +60.0% | 1,354 | +62.2% | 0.00% | 0.0% |
| Q3 2017 | $5,000 | +66.7% | 835 | +59.0% | 0.00% | – |
| Q2 2017 | $3,000 | +50.0% | 525 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | -50.0% | 525 | -12.5% | 0.00% | – |
| Q4 2016 | $4,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |